Comparison between monitored anesthesia care and general anesthesia in patients undergoing device closure of atrial septal defect

• DOI: 10.21037/jtd.2019.03.56
• Publication Date: 2019-04-30T07:44:43Z
• Authors: Yong-Seok Park; Dae-Kee Choi; Jiwon Kang; Jihoon Park; Kyoung-Woon Joung; In-Cheol Choi
• Keywords: Dexmedetomidine; Aspiration Pneumonia; Sore throat

Percutaneous atrial septal defect (ASD) device closure is usually performed under general anesthesia (GA) because it can ensure protection of the airway from effects insertion transesophageal echocardiogram probe insertion. However, recent studies have suggested that this procedure be safely deep sedation also. Thus, we compared efficacy using monitored care (MAC) with versus GA to perform and post-procedural outcomes incidence complications associated these two methods anesthesia.We retrospectively analyzed cases involving 311 patients who underwent ASD closures January 2011 December 2015. The demographics, laboratory values, echocardiographic findings, intraoperative data were assessed. was induced a continuous infusion propofol remifentanil target control pump. MAC by dexmedetomidine remifentanil. primary outcome study overall complication rate included aspiration pneumonia, sore throat, dysphagia, vocal cord palsy, neurologic complication, device-related complications, other minor during procedure; secondary turnover time, duration hospital stay.No significant differences observed in length stay between group group. time significantly longer than (56.2±13.3 vs. 51.0±15.4 min, P=0.004).MAC an effective safe anesthetic option comparable for performing percutaneous closures.